TickerFacts.

Burning Rock Biotech Ltd (BNR): Gross Profit

Annual figures by period end, from SEC filings.

402.91M CNY
Year ended 2025-12-31
+2.0%
3-year compound annual growth
+5.1%
5-year compound annual growth
2018-12-31: 135.06M CNY2019-12-31: 273.33M CNY2020-12-31: 313.92M CNY2021-12-31: 364.15M CNY2022-12-31: 380.04M CNY2023-12-31: 363.23M CNY2024-12-31: 362.40M CNY2025-12-31: 402.91M CNY402.91M CNY
2018-12-31 Gross Profit (CNY) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31402.91M CNY+11.2%2026-04-28, From 2025-01-01
2024-12-31362.40M CNY-0.2%2026-04-28, From 2024-01-01
2023-12-31363.23M CNY-4.4%2026-04-28, From 2023-01-01
2022-12-31380.04M CNY+4.4%2025-04-29, From 2022-01-01
2021-12-31364.15M CNY+16.0%2024-04-29, From 2021-01-01
2020-12-31313.92M CNY+14.8%2023-04-20, From 2020-01-01
2019-12-31273.33M CNY+102.4%2022-04-29, From 2019-01-01
2018-12-31135.06M CNYn/a2021-03-23, From 2018-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31402.91M CNY+11.2%
Concord Medical Services Holdings Ltd (CCM)2025-12-3125.82M CNYn/m

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗